| __timestamp | Summit Therapeutics Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 6795238 | 2999000 |
| Thursday, January 1, 2015 | 7454247 | 10393000 |
| Friday, January 1, 2016 | 10345862 | 15994000 |
| Sunday, January 1, 2017 | 16984203 | 26975000 |
| Monday, January 1, 2018 | 16187290 | 39509000 |
| Tuesday, January 1, 2019 | 9299233.54 | 48869000 |
| Wednesday, January 1, 2020 | 19232000 | 42510000 |
| Friday, January 1, 2021 | 23611000 | 46105000 |
| Saturday, January 1, 2022 | 26700000 | 50513000 |
| Sunday, January 1, 2023 | 28215000 | 51292000 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing operational costs is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Summit Therapeutics Inc. and Wave Life Sciences Ltd. from 2014 to 2023. Over this period, Wave Life Sciences consistently outpaced Summit Therapeutics in SG&A spending, with a peak in 2023 where their expenses were nearly 82% higher. Summit Therapeutics, however, showed a steady increase, with a notable 315% rise from 2014 to 2023. This trend highlights the strategic financial decisions each company has made in their quest for innovation and market leadership. Understanding these expenses provides insight into their operational strategies and potential future growth.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Summit Therapeutics Inc.
Operational Costs Compared: SG&A Analysis of Alnylam Pharmaceuticals, Inc. and Wave Life Sciences Ltd.
BeiGene, Ltd. or Wave Life Sciences Ltd.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: United Therapeutics Corporation vs Summit Therapeutics Inc.
Neurocrine Biosciences, Inc. and Summit Therapeutics Inc.: SG&A Spending Patterns Compared
Incyte Corporation vs Wave Life Sciences Ltd.: SG&A Expense Trends
Intra-Cellular Therapies, Inc. vs Summit Therapeutics Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Merus N.V. Trends and Insights
Summit Therapeutics Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Wave Life Sciences Ltd. Trends and Insights
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.
Wave Life Sciences Ltd. and Novavax, Inc.: SG&A Spending Patterns Compared